Limcee
Limcee Price range: $ 21,00 through $ 39,00
Back to products
Lioresal
Lioresal Price range: $ 52,00 through $ 478,00

Lincocin

Price range: $ 75,00 through $ 1 080,00

Lincocin is a potent antibiotic medication containing lincomycin, primarily used to treat serious bacterial infections. It is highly effective against susceptible strains of streptococci, pneumococci, and staphylococci. This medication is commonly utilized for conditions such as severe respiratory tract infections and complex skin or soft tissue issues. Additionally, it serves as a critical treatment option for patients managing bone and joint infections caused by sensitive organisms. Lincocin works by inhibiting bacterial protein synthesis, effectively stopping the growth and spread of harmful bacteria throughout the body.

Active substance: Lincomycin
SKU: Lincocin Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Lincocin belongs to a group of medicines called lincosamide antibiotics, which are specifically formulated to treat severe bacterial infections in adults and pediatric patients. In the United States, this medication is available strictly as a prescription-only drug, dispensed under the guidance of a licensed healthcare provider in accordance with federal regulations.

While Lincocin provides an essential treatment option for individuals who cannot tolerate penicillins, its clinical use involves a careful balance between bactericidal activity and potential risk factors. On one hand, it effectively targets specific gram-positive pathogens; on the other hand, its association with serious gastrointestinal complications requires vigilant clinical oversight throughout the treatment course.

Property Details
Active ingredient Lincomycin (as hydrochloride)
Therapeutic class Lincosamide antibiotic
Dosage form Injectable solution, oral capsule
Route of administration Intravenous, intramuscular, oral
Prescription status Prescription (Rx) only
Primary purpose Treatment of serious susceptible bacterial infections

How the drug works

Lincomycin inhibits bacterial protein synthesis by reversibly binding to the 50S ribosomal subunit of susceptible microorganisms. This action blocks the peptide bond formation step, effectively preventing bacterial cell growth and replication. Depending on the concentration of the drug at the infection site and the specific sensitivity of the pathogen, lincomycin may exert either bacteriostatic or bactericidal effects. Its spectrum of activity primarily encompasses gram-positive aerobic bacteria, including Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. However, it displays virtually no clinical activity against gram-negative aerobic bacilli or enterococci, making accurate pathogen identification essential prior to therapy.

What it’s used for

Lincocin is indicated for the treatment of serious bacterial infections caused by susceptible strains of streptococci, pneumococci, and staphylococci. It is typically reserved for patients who have demonstrated hypersensitivity to penicillin antibiotics or for whom penicillin therapy is otherwise inappropriate. Approved clinical indications include severe lower respiratory tract infections, such as empyema and pneumonia, as well as complex skin and soft tissue infections, bone and joint infections (such as osteomyelitis), and septicemia. In certain clinical contexts, off-label use–such as off-label adjunctive treatment for specific polymicrobial soft-tissue infections–may be considered by specialists, though such uses are not formally designated in the primary FDA-approved prescribing information.

What happens in the body

Following oral administration, lincomycin is rapidly absorbed from the gastrointestinal tract, achieving peak serum levels within 2 to 4 hours, though food significantly reduces its bioavailability. When administered intramuscularly, peak plasma concentrations occur within 30 minutes to 2 hours. The drug distributes widely into most body tissues and fluids, including bone matrix, pleural fluid, and peritoneal fluid, though penetration into cerebrospinal fluid remains minimal even in the presence of inflamed meninges. Lincomycin undergoes partial hepatic metabolism and is excreted in bile, feces, and urine. The elimination half-life in individuals with normal renal and hepatic function is approximately 5.4 hours, but this duration may be significantly prolonged in patients with severe renal or hepatic impairment.

Dosing schedule

The dosing schedule for Lincocin is strictly determined by a physician based on the location and severity of the infection, patient body weight, and renal function. Intramuscular administration for severe infections in adults typically involves standard doses administered every 12 to 24 hours. When prescribed intravenously, lincomycin must be diluted in an appropriate infusion solution and administered slowly over a period of at least 60 minutes; rapid intravenous bolus injection is strictly prohibited due to the risk of severe cardiopulmonary adverse events. For patients with severe renal insufficiency, dosage adjustments or extended dosing intervals are required to prevent systemic drug accumulation.

Compatibility with other medicines

Lincomycin exhibits important pharmacokinetic and pharmacodynamic interactions when combined with other pharmacologic agents. Co-administration with erythromycin is not recommended due to competitive binding at the bacterial 50S ribosomal subunit, which can result in mutual antagonism. In addition, lincomycin possesses inherent neuromuscular blocking properties that may enhance the action of neuromuscular blocking agents used during surgical procedures, such as pancuronium or vecuronium, potentially leading to prolonged respiratory depression. Concomitant use of kaolin-pectin antidiarrheal mixtures significantly reduces the oral absorption of lincomycin and should be avoided unless dosing times are appropriately separated.

Adverse reactions

While Lincocin can be highly effective against susceptible organisms, it carries a distinct risk of adverse reactions. Gastrointestinal effects are the most frequent, ranging from nausea, vomiting, and abdominal pain to severe persistent diarrhea. The most critical adverse event associated with lincomycin is Clostridioides difficile-associated diarrhea (CDAD), which can range in severity from mild diarrhea to fatal pseudomembranous colitis. Hypersensitivity reactions, including skin rashes, urticaria, and rarely, severe bullous dermatoses like Stevens-Johnson syndrome, have been reported. Hematologic side effects may include transient leukopenia, neutropenia, and thrombocytopenia. Local reactions at injection sites, such as pain or sterile abscess formation following intramuscular injection, may also occur.

Important precautions

Lincocin should be prescribed with extreme caution in patients with a history of gastrointestinal disease, particularly colitis. Patients must be monitored closely for signs of severe diarrhea during and several weeks following therapy. Pediatric formulations containing benzyl alcohol as a preservative are contraindicated in neonates due to the risk of “gasping syndrome.” Pregnant women should receive lincomycin only if clearly needed, as safety data in human pregnancy remains limited. Furthermore, lincomycin is excreted in human breast milk; healthcare providers must decide whether to discontinue nursing or discontinue the drug, taking into account the importance of the medication to the mother.

What to avoid while taking it

When taking oral formulations of lincomycin, food should be avoided immediately before and after administration, as dietary intake significantly impairs drug absorption; oral doses should be taken on an empty stomach at least 1 hour before or 2 hours after meals. While alcohol does not directly alter the metabolic pathway of lincomycin, consuming alcohol during treatment for a severe bacterial infection can exacerbate gastrointestinal side effects and strain liver function. Additionally, anti-peristaltic antidiarrheal medications should be avoided if severe diarrhea occurs, as delaying toxin clearance can worsen C. difficile colitis.

If you skip a dose

Adherence to the prescribed administration schedule is critical for maintaining effective blood concentrations and preventing the emergence of bacterial resistance. If an oral dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next scheduled dose. Patients should never double the dose to compensate for a missed one. For patients receiving intravenous or intramuscular doses in a clinical setting, healthcare personnel will manage the infusion schedule to ensure consistent therapeutic drug levels.

Red flags

Immediate medical evaluation is necessary if severe warning signs develop during or after treatment with Lincocin. Key signs requiring urgent emergency care include:

  • Severe, watery diarrhea occurring multiple times per day, especially if accompanied by stomach cramps or fever
  • Signs of a severe allergic reaction, such as swelling of the face, lips, tongue, or throat, and difficulty breathing
  • Unusual skin peeling, blistering, or widespread skin eruption
  • Yellowing of the skin or eyes (jaundice) or dark urine
  • Unexplained bleeding, severe fatigue, or persistent high fever

Storage and expiration

Lincocin vials and oral dosage forms should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), away from excessive heat, moisture, and direct light. Injectable solutions must be protected from freezing. Keep all formulations securely out of the reach of children and pets. Do not use any medication past the expiration date printed on the container package.

Common questions

Can Lincocin cause severe diarrhea weeks after finishing the course?

Yes. Clostridioides difficile-associated diarrhea can manifest during treatment or up to several weeks after stopping lincomycin therapy, because altered intestinal microflora can take time to recover. If you experience persistent or watery diarrhea after completing your prescription, contact your doctor promptly.

How does lincomycin differ from clindamycin?

Lincomycin and clindamycin are both lincosamide antibiotics, but clindamycin is a semi-synthetic derivative of lincomycin. Clindamycin generally exhibits higher oral absorption, greater antibacterial potency, and a slightly broader spectrum of activity. Healthcare providers select between them based on infection severity, route requirements, and specific clinical guidelines.

Is dose modification necessary for patients with kidney problems?

Yes. In patients with severe renal impairment, the elimination half-life of lincomycin is prolonged. Physicians adjust the dose or extend the interval between doses to prevent drug accumulation and toxicity while maintaining effective antimicrobial activity.

Can lincomycin be given as a quick intravenous injection?

No. Rapid intravenous injection of lincomycin can trigger serious cardiovascular complications, including severe hypotension and cardiac arrest. Intravenous doses must always be diluted and infused slowly over a minimum period of 60 minutes.

In accordance with FDA requirements.

This material is educational. Only a licensed prescriber can determine whether a medication is appropriate for you.

Additional information
Dosage

500mg

Package

10 pills

,

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία